*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C9201 - Acute myeloblastic leukemia, in remission - as a primary diagnosis code | C9201 - Acute myeloblastic leukemia, in remission - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 8.72 | |
| Readmission Rate (%) | 34.99 | |
| Unplanned Readmission Rate (%) | 9.02 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 835: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 836: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 3,410 | ||||
| Total Hospitalizations with ICD C9201 - Acute myeloblastic leukemia, in remission | 458 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C9201 - Acute myeloblastic leukemia, in remission in DRG | 71.01 | ||||
| Avg LOS at DRG | 27.15 | ||||
| Avg LOS with ICD C9201 - Acute myeloblastic leukemia, in remission | 25.35 | ||||
| Readmission Rate at DRG | 28.76 | ||||
| Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 24.55 | ||||
| Unplanned Readmission Rate at DRG | 8.51 | ||||
| Unplanned Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 7.27 | ||||
| Total Medicare payments at DRG | $316,670,719 | ||||
| Total Medicare payments with ICD C9201 - Acute myeloblastic leukemia, in remission | $41,384,386 | ||||
| Total Medicare payment per Day at DRG | $3,421 | ||||
| Total Medicare payment per Day with ICD C9201 - Acute myeloblastic leukemia, in remission | $3,564 | ||||
| Total Medicare payment per Hospitalization at DRG | $92,865 | ||||
| Total Medicare payment per Hospitalization with ICD C9201 - Acute myeloblastic leukemia, in remission | $90,359 | ||||
| Total Medicare Charges at DRG | $1,488,215,147 | ||||
| Total Medicare Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $178,868,627 | ||||
| Avg Charges at DRG | $436,427 | ||||
| Avg Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $390,543 | ||||
| Mortality Rate at DRG | 4.96 | ||||
| Mortality Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 2.84 | ||||
| SNF Discharge Rate at DRG | 0.88 | ||||
| SNF Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | NA | ||||
| Home Discharge Rate at DRG | 65.84 | ||||
| Home Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 67.25 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| CITY OF HOPE DUARTE | 1500 E DUARTE RD | DUARTE | CA | 91010 | 38 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 34 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 25 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 838: CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 3,028 | ||||
| Total Hospitalizations with ICD C9201 - Acute myeloblastic leukemia, in remission | 550 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C9201 - Acute myeloblastic leukemia, in remission in DRG | 6.88 | ||||
| Avg LOS at DRG | 5.03 | ||||
| Avg LOS with ICD C9201 - Acute myeloblastic leukemia, in remission | 4.75 | ||||
| Readmission Rate at DRG | 59.48 | ||||
| Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 53.75 | ||||
| Unplanned Readmission Rate at DRG | 19.21 | ||||
| Unplanned Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 19.85 | ||||
| Total Medicare payments at DRG | $33,141,664 | ||||
| Total Medicare payments with ICD C9201 - Acute myeloblastic leukemia, in remission | $5,447,246 | ||||
| Total Medicare payment per Day at DRG | $2,176 | ||||
| Total Medicare payment per Day with ICD C9201 - Acute myeloblastic leukemia, in remission | $2,085 | ||||
| Total Medicare payment per Hospitalization at DRG | $10,945 | ||||
| Total Medicare payment per Hospitalization with ICD C9201 - Acute myeloblastic leukemia, in remission | $9,904 | ||||
| Total Medicare Charges at DRG | $136,817,975 | ||||
| Total Medicare Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $15,753,808 | ||||
| Avg Charges at DRG | $45,184 | ||||
| Avg Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $28,643 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | NA | ||||
| SNF Discharge Rate at DRG | 0.43 | ||||
| SNF Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | NA | ||||
| Home Discharge Rate at DRG | 82.2 | ||||
| Home Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 84.73 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 919: COMPLICATIONS OF TREATMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 45,432 | ||||
| Total Hospitalizations with ICD C9201 - Acute myeloblastic leukemia, in remission | 319 | ||||
| DRG Share of Total Hospitalizations | 0.14 | ||||
| % of Total ICD C9201 - Acute myeloblastic leukemia, in remission in DRG | 3.99 | ||||
| Avg LOS at DRG | 4.42 | ||||
| Avg LOS with ICD C9201 - Acute myeloblastic leukemia, in remission | 5.29 | ||||
| Readmission Rate at DRG | 30.74 | ||||
| Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 43.14 | ||||
| Unplanned Readmission Rate at DRG | 18.94 | ||||
| Unplanned Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 10.78 | ||||
| Total Medicare payments at DRG | $376,347,273 | ||||
| Total Medicare payments with ICD C9201 - Acute myeloblastic leukemia, in remission | $3,112,297 | ||||
| Total Medicare payment per Day at DRG | $1,873 | ||||
| Total Medicare payment per Day with ICD C9201 - Acute myeloblastic leukemia, in remission | $1,845 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,284 | ||||
| Total Medicare payment per Hospitalization with ICD C9201 - Acute myeloblastic leukemia, in remission | $9,756 | ||||
| Total Medicare Charges at DRG | $1,794,383,177 | ||||
| Total Medicare Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $15,191,597 | ||||
| Avg Charges at DRG | $39,496 | ||||
| Avg Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $47,623 | ||||
| Mortality Rate at DRG | 0.61 | ||||
| Mortality Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | NA | ||||
| SNF Discharge Rate at DRG | 7.48 | ||||
| SNF Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | NA | ||||
| Home Discharge Rate at DRG | 67.79 | ||||
| Home Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 78.37 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 12,641 | ||||
| Total Hospitalizations with ICD C9201 - Acute myeloblastic leukemia, in remission | 110 | ||||
| DRG Share of Total Hospitalizations | 0.04 | ||||
| % of Total ICD C9201 - Acute myeloblastic leukemia, in remission in DRG | 1.38 | ||||
| Avg LOS at DRG | 16.42 | ||||
| Avg LOS with ICD C9201 - Acute myeloblastic leukemia, in remission | 20.55 | ||||
| Readmission Rate at DRG | 41.54 | ||||
| Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 44.33 | ||||
| Unplanned Readmission Rate at DRG | 17.96 | ||||
| Unplanned Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 12.37 | ||||
| Total Medicare payments at DRG | $591,889,384 | ||||
| Total Medicare payments with ICD C9201 - Acute myeloblastic leukemia, in remission | $4,829,627 | ||||
| Total Medicare payment per Day at DRG | $2,852 | ||||
| Total Medicare payment per Day with ICD C9201 - Acute myeloblastic leukemia, in remission | $2,137 | ||||
| Total Medicare payment per Hospitalization at DRG | $46,823 | ||||
| Total Medicare payment per Hospitalization with ICD C9201 - Acute myeloblastic leukemia, in remission | $43,906 | ||||
| Total Medicare Charges at DRG | $2,437,161,576 | ||||
| Total Medicare Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $21,083,266 | ||||
| Avg Charges at DRG | $192,798 | ||||
| Avg Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $191,666 | ||||
| Mortality Rate at DRG | 21.77 | ||||
| Mortality Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | NA | ||||
| SNF Discharge Rate at DRG | 6.6 | ||||
| SNF Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | NA | ||||
| Home Discharge Rate at DRG | 30.51 | ||||
| Home Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 65.45 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 522,791 | ||||
| Total Hospitalizations with ICD C9201 - Acute myeloblastic leukemia, in remission | 104 | ||||
| DRG Share of Total Hospitalizations | 1.59 | ||||
| % of Total ICD C9201 - Acute myeloblastic leukemia, in remission in DRG | 1.3 | ||||
| Avg LOS at DRG | 3.14 | ||||
| Avg LOS with ICD C9201 - Acute myeloblastic leukemia, in remission | 4.56 | ||||
| Readmission Rate at DRG | 17.1 | ||||
| Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 32.32 | ||||
| Unplanned Readmission Rate at DRG | 12.62 | ||||
| Unplanned Readmission Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 14.14 | ||||
| Total Medicare payments at DRG | $2,290,151,156 | ||||
| Total Medicare payments with ICD C9201 - Acute myeloblastic leukemia, in remission | $864,389 | ||||
| Total Medicare payment per Day at DRG | $1,394 | ||||
| Total Medicare payment per Day with ICD C9201 - Acute myeloblastic leukemia, in remission | $1,824 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,381 | ||||
| Total Medicare payment per Hospitalization with ICD C9201 - Acute myeloblastic leukemia, in remission | $8,311 | ||||
| Total Medicare Charges at DRG | $13,619,287,561 | ||||
| Total Medicare Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $4,151,408 | ||||
| Avg Charges at DRG | $26,051 | ||||
| Avg Charges with ICD C9201 - Acute myeloblastic leukemia, in remission | $39,917 | ||||
| Mortality Rate at DRG | 0.18 | ||||
| Mortality Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | NA | ||||
| SNF Discharge Rate at DRG | 8.57 | ||||
| SNF Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | NA | ||||
| Home Discharge Rate at DRG | 72.49 | ||||
| Home Discharge Rate with ICD C9201 - Acute myeloblastic leukemia, in remission | 79.81 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 274 |
| CITY OF HOPE DUARTE | 1500 E DUARTE RD | DUARTE | CA | 91010 | 211 |
| BARNES JEWISH HOSPITAL | 1 BARNES-JEWISH HOSPITAL PLZ | SAINT LOUIS | MO | 63110 | 131 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MELISSA LEIGH LARSON | 1725 W HARRISON ST | CHICAGO | IL | 60612 | 36 |
| Dr. GUIDO MARCUCCI | 300 W 10TH AVE | COLUMBUS | OH | 43210 | 15 |
| Dr. ETSUKO AOKI | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 14 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MELISSA LEIGH LARSON | 1725 W HARRISON ST | CHICAGO | IL | 60612 | 66 |
| Dr. VINOD PULLARKAT | 1441 EASTLAKE AVE | LOS ANGELES | CA | 90089 | 24 |
| Dr. AHMED ARIBI | 1500 DUARTE RD | DUARTE | CA | 91010 | 21 |